Opportunistic Eye Disease Screening in Mazovia, Poland: Lessons from a Local Government Program: “Good Vision for Mazovians”
Abstract
1. Introduction
2. Materials and Methods
2.1. Study Design and Population
2.2. Measures
- Intraocular pressure elevated above 21 mmHg, weighted with central corneal thickness correction measured in tonometry.
- Optic nerve damage assessed in OCT scans is shown as retinal nerve fiber layer loss.
- Reports suggesting glaucoma from Fundus Imaging System, such as an enlarged optic cup or a large cup-to-disc ratio, vertical elongation of the cup, notching or thinning of the neuroretinal rim, and nasal displacement of the vessels.
2.3. Statistical Analysis
3. Results
| Have You Visited an Ophthalmologist in the Last 2 Years?—“Yes” | Do You Have Difficulty Accessing an Ophthalmologist in Your Region?—“Yes” | In Your Place of Residence, Is There Access to an Optician’s Shop Where You Can Buy Glasses or Contact Lenses?—“Yes” | Would You Like to Improve Your Knowledge About Eye Diseases?—“Yes” | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | % | p | n | % | p | n | % | p | n | % | p | |
| Overall (n = 1812) | 750 | 41.4 | 1033 | 57.0 | 1151 | 63.5 | 1158 | 63.9 | ||||
| Variable | ||||||||||||
| Gender | ||||||||||||
| Female (n = 1081) | 481 | 44.5 | 0.001 | 669 | 61.9 | <0.001 | 912 | 84.4 | 0.2 | 969 | 88.7 | 0.09 |
| Male (n = 731) | 269 | 36.8 | 364 | 49.8 | 599 | 81.9 | 629 | 86.0 | ||||
| Age | ||||||||||||
| <30 (n = 73) | 38 | 52.1 | <0.001 | 17 | 23.3 | <0.001 | 64 | 87.7 | 0.1 | 57 | 78.1 | <0.001 |
| 30–39 (n = 94) | 31 | 33.0 | 38 | 40.4 | 84 | 89.4 | 75 | 79.8 | ||||
| 40–49 (n = 292) | 105 | 36.0 | 142 | 48.6 | 255 | 87.3 | 243 | 83.2 | ||||
| 50–59 (n = 291) | 100 | 34.4 | 158 | 54.3 | 245 | 84.2 | 258 | 88.7 | ||||
| 60–69 (n = 513) | 208 | 40.5 | 334 | 65.1 | 418 | 81.5 | 467 | 91.0 | ||||
| 70–79 (n = 465) | 222 | 47.7 | 288 | 61.0 | 377 | 81.1 | 415 | 89.2 | ||||
| 80+ (n = 84) | 46 | 54.8 | 56 | 66.7 | 68 | 81.0 | 73 | 86.9 | ||||
| Educational level | ||||||||||||
| Primary (n = 108) | 43 | 39.8 | 0.002 | 67 | 62.0 | 0.07 | 67 | 62.0 | <0.001 | 88 | 81.5 | 0.06 |
| Vocational (n = 370) | 113 | 35.9 | 223 | 60.3 | 268 | 72.4 | 334 | 90.3 | ||||
| Secondary (n = 715) | 281 | 39.3 | 415 | 58.0 | 615 | 86.0 | 632 | 88.4 | ||||
| Higher (n = 619) | 293 | 47.3 | 328 | 53.0 | 561 | 90.6 | 534 | 86.3 | ||||
| Taking medications on a regular basis | ||||||||||||
| Yes (n = 1137) | 507 | 44.6 | <0.001 | 697 | 61.3 | <0.001 | 938 | 82.5 | 0.2 | 1018 | 89.5 | 0.001 |
| No (n = 675) | 243 | 36.0 | 336 | 49.8 | 573 | 84.9 | 570 | 84.4 | ||||
| Do you smoke cigarettes, use e-cigarettes, or heated tobacco? | ||||||||||||
| Yes (n = 306) | 121 | 39.5 | 0.5 | 189 | 61.8 | 0.07 | 252 | 82.4 | 0.6 | 262 | 85.6 | 0.2 |
| No (n = 1506) | 629 | 41.8 | 844 | 56.0 | 1259 | 83.6 | 1326 | 88.0 | ||||
| Research site | ||||||||||||
| No 1. (Bodzanów) (n = 159) | 53 | 33.3 | 0.2 | 99 | 62.3 | <0.001 | 51 | 32.1 | <0.001 | 138 | 86.8 | 0.001 |
| No 2. (Ciechanów) (n = 289) | 113 | 39.1 | 201 | 69.6 | 250 | 86.5 | 255 | 88.2 | ||||
| No 3. (Warsaw–Wilanów District) (n = 107) | 41 | 38.3 | 47 | 43.9 | 96 | 92.9 | 83 | 77.6 | ||||
| No 4. (Legionowo) (n = 108) | 41 | 38.0 | 38 | 35.2 | 101 | 93.5 | 93 | 86.1 | ||||
| No 5. (Ostrołęka) (n = 148) | 67 | 45.3 | 83 | 56.1 | 129 | 87.2 | 133 | 89.9 | ||||
| No 6. (Płock) (n = 319) | 140 | 43.9 | 237 | 74.3 | 283 | 88.7 | 300 | 94.0 | ||||
| No 7. (Radom) (n = 335) | 135 | 40.3 | 176 | 52.5 | 288 | 86.0 | 290 | 86.6 | ||||
| No 8. (Siedlce) (n = 170) | 78 | 45.9 | 60 | 35.3 | 158 | 92.9 | 147 | 86.5 | ||||
| No 9. (Żyrardów) (n = 177) | 82 | 46.3 | 92 | 52.0 | 155 | 87.6 | 149 | 84.2 | ||||
4. Discussion
Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- GBD 2019 Blindness and Vision Impairment Collaborators. Trends in Prevalence of Blindness and Distance and near Vision Impairment over 30 Years: An Analysis for the Global Burden of Disease Study. Lancet Glob. Health 2020, 9, e130–e143. [Google Scholar] [CrossRef]
- Teo, Z.L.; Tham, Y.-C.; Yu, M.; Chee, M.L.; Rim, T.H.; Cheung, N.; Bikbov, M.M.; Wang, Y.X.; Tang, Y.; Lu, Y.; et al. Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-Analysis. Ophthalmology 2021, 128, 1580–1591. [Google Scholar] [CrossRef]
- Lin, Y.; Jiang, B.; Cai, Y.; Luo, W.; Zhu, X.; Lin, Q.; Tang, M.; Li, X.; Xie, L. The Global Burden of Glaucoma: Findings from the Global Burden of Disease 2019 Study and Predictions by Bayesian Age–Period–Cohort Analysis. J. Clin. Med. 2023, 12, 1828. [Google Scholar] [CrossRef]
- Zhou, Y.; Jia, W.; Song, J.; Li, M.; Dai, W.; Zou, J.; Zhou, J.; Chen, X.; Li, X. Burdens and Trends of Age-Related Macular Degeneration at Global, Regional, and National Levels,1990–2021: Findings from the 2021 Global Burden of Disease Study. Eye 2025, 39, 1517–1525. [Google Scholar] [CrossRef] [PubMed]
- GBD 2019 Blindness and Vision Impairment Collaborators. Causes of Blindness and Vision Impairment in 2020 and Trends over 30 Years, and Prevalence of Avoidable Blindness in Relation to VISION 2020: The Right to Sight: An Analysis for the Global Burden of Disease Study. Lancet Glob. Health 2020, 9, e144–e160. [Google Scholar] [CrossRef]
- Sagan, A.; Panteli, D.; Borkowski, W.; Dmowski, M.; Domanski, F.; Czyżewski, M.; Goryński, P.; Karpacka, D.; Kiersztyn, E.; Kowalska, I.; et al. Poland health system review. Health Syst. Transit. 2011, 13, 1–193. [Google Scholar]
- Solomon, S.D.; Shoge, R.Y.; Ervin, A.M.; Contreras, M.; Harewood, J.; Aguwa, U.T.; Olivier, M.M.G. Improving Access to Eye Care A Systematic Review of the Literature. Ophthalmology 2022, 129, e114–e126. [Google Scholar] [CrossRef]
- Kamińska, A.; Pinkas, J.; Jankowski, M. Factors Associated with the Frequency of Eye Examinations among Adults in Poland—A Nationwide Cross-Sectional Survey, December 2022. Ann. Agric. Environ. Med. 2023, 30, 287–295. [Google Scholar] [CrossRef]
- Kamińska, A.; Pinkas, J.; Wrześniewska-Wal, I.; Ostrowski, J.; Jankowski, M. Awareness of Common Eye Diseases and Their Risk Factors—A Nationwide Cross-Sectional Survey among Adults in Poland. Int. J. Environ. Res. Public Health 2023, 20, 3594. [Google Scholar] [CrossRef] [PubMed]
- Kamiński, M.; Jankowski, M.; Adamska, O.; Pinkas, J.; Kamińska, A. An Analysis of Health Policy Programmes on Eye Health Implemented by Local Government Units (LGUs) in Poland, 2015–2023. Ann. Agric. Environ. Med. 2024, 31, 388–394. [Google Scholar] [CrossRef]
- Kurowska, P.; Królak, A.; Giermaziniak, W. Health policy programs realised in Poland in 2016–2017. Rocz. Państwowego Zakładu Hig. 2018, 69, 209–217. [Google Scholar]
- Founti, P.; Stuart, K.; Nolan, W.P.; Khawaja, A.P.; Foster, P.J. Screening Strategies and Methodologies. J. Glaucoma 2024, 33 (Suppl. S1), S15–S20. [Google Scholar] [CrossRef]
- Hristova, E.; Koseva, D.; Zlatarova, Z.; Dokova, K. Diabetic Retinopathy Screening and Registration in Europe—Narrative Review. Healthcare 2021, 9, 745. [Google Scholar] [CrossRef] [PubMed]
- Kozioł, M.; Nowak, M.S.; Udziela, M.; Piątkiewicz, P.; Grabska-Liberek, I.; Szaflik, J.P. First Nation-wide Study of Diabetic Retinopathy in Poland in the Years 2013–2017. Acta Diabetol. 2020, 57, 1255–1264. [Google Scholar] [CrossRef]
- Moghimi, S.; Weinreb, R.N. Screening of glaucoma: Consensus and directions. J. Glaucoma 2024, 33, S75–S77. [Google Scholar] [CrossRef] [PubMed]
- Ben, Â.J.; Neyeloff, J.L.; de Souza, C.F.; Rosses, A.P.O.; de Araujo, A.L.; Szortika, A.; Locatelli, F.; de Carvalho, G.; Neumann, C.R. Cost-utility Analysis of Opportunistic and Systematic Diabetic Retinopathy Screening Strategies from the Perspective of the Brazilian Public Healthcare System. Appl. Health Econ. Health Policy 2020, 18, 57–68. [Google Scholar] [CrossRef]
- Alqahtani, A.S.; Alshareef, W.M.; Aljadani, H.T.; Hawsawi, W.O.; Shaheen, M.H. The Efficacy of Artificial Intelligence in Diabetic Retinopathy Screening: A Systematic Review and Meta-Analysis. Int. J. Retin. Vitr. 2025, 11, 48. [Google Scholar] [CrossRef]
- Mazovia Heart of Poland. “Vision for Mazovians”. 2024. Available online: http://mazovia.pl/pl/zdrowie_i_polityka_spoleczna/aktualnosci/dobry-wzrok-mazowszan-zbadaj-sie.html (accessed on 24 July 2025).
- Spaeth, G.L. European Glaucoma Society Terminology and Guidelines for Glaucoma, 5th Edition. Br. J. Ophthalmol. 2021, 105 (Suppl. S1), 1–169. [Google Scholar] [CrossRef]
- NICE Guideline. Age-Related Macular Degeneration Diagnosis and Management; National Institute for Health and Care Excellence (NICE): London, UK, 2018; p. 82, ISBN-13: 978-1-4731-2787-6. [Google Scholar]
- Wilkinson, C.P.; Ferris, F.L., 3rd; Klein, R.E.; Lee, P.P.; Agardh, C.D.; Davis, M.; Dills, D.; Kampik, A.; Pararajasegaram, R.; Verdaguer, J.T. Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003, 110, 1677–1682. [Google Scholar] [CrossRef]
- Polish Diabetes Association. Clinical Recommendations for the Management of People with Diabetes—2024. Position of the Polish Diabetes Association. Off. J. Diabetes Pol. 2023, 4, 3–4. [Google Scholar]
- Nowak, M.S.; Smigielski, J. The Prevalence of Age-Related Eye Diseases and Cataract Surgery among Older Adults in the City of Lodz, Poland. J. Ophthalmol. 2015, 2015, 605814. [Google Scholar] [CrossRef] [PubMed]
- Kamińska, A.; Pinkas, J.; Tyszko, P.; Wrześniewska-Wal, I.; Jankowski, M. Eye Care Behaviors among Adults in Poland: A Nationwide Cross-Sectional Survey. Int. J. Environ. Res. Public. Health 2023, 20, 3590. [Google Scholar] [CrossRef] [PubMed]
- Babaker, R.; Alzimami, L.; Al Ameer, A.; Almutairi, M.; Alam Aldeen, R.; Alshatti, H.; Al-Johani, N.; Al Taisan, A. Risk Factors for Age-Related Macular Degeneration: Updated Systematic Review and Meta-Analysis. Medicine 2025, 104, e41599. [Google Scholar] [CrossRef] [PubMed]
- Xu, D.; Xu, S.; Zheng, K.; Zhang, M. Barriers and Facilitators to Age-Friendly Health Care: A Scoping Review. J. Adv. Nurs. 2025, 81, 3564–3582. [Google Scholar] [CrossRef]
- Rosdahl, J.A.; Swamy, L.; Stinnett, S.; Muir, K.W. Patient Education Preferences in Ophthalmic Care. Patient Prefer. Adherence 2014, 8, 565–574. [Google Scholar] [CrossRef]
- European Council of Optometry and Optics. Regulation of the Optometric Profession in Poland. Available online: https://ecoo.info/2024/06/regulation-of-the-optometric-profession-in-poland/ (accessed on 7 September 2025).
- Journal of Laws of the Republic of Poland. Act of 17 August 2023 on Certain Medical Professions. Item 1972. Available online: https://api.sejm.gov.pl/eli/acts/DU/2023/1972/text.pdf (accessed on 7 September 2025).
| Variable | n | % |
|---|---|---|
| Gender | ||
| Female | 1081 | 59.7 |
| Male | 731 | 40.3 |
| Age | ||
| <30 | 73 | 4.0 |
| 30–39 | 94 | 5.2 |
| 40–49 | 292 | 16.1 |
| 50–59 | 291 | 16.1 |
| 60–69 | 513 | 28.3 |
| 70–79 | 465 | 25.7 |
| 80+ | 84 | 4.6 |
| Educational level | ||
| Primary | 108 | 6.0 |
| Vocational | 370 | 20.4 |
| Secondary | 715 | 39.5 |
| Higher | 619 | 34.2 |
| Taking medications on a regular basis | ||
| Yes | 1137 | 62.7 |
| No | 675 | 37.3 |
| Has a doctor ever diagnosed you with any chronic diseases? | ||
| Hypertension | 748 | 41.3 |
| Heart disease | 311 | 17.2 |
| Lung disease | 120 | 6.6 |
| Diabetes | 213 | 11.8 |
| Do you smoke cigarettes, use e-cigarettes, or heated tobacco? | ||
| Yes | 306 | 16.9 |
| No | 1506 | 83.1 |
| Research site | ||
| No 1. (Bodzanów) | 159 | 8.8 |
| No 2. (Ciechanów) | 289 | 15.9 |
| No 3. (Wilanów District) | 107 | 5.9 |
| No 4. (Legionowo) | 108 | 6.0 |
| No 5. (Ostrołęka) | 148 | 8.2 |
| No 6. (Płock) | 319 | 17.6 |
| No 7. (Radom) | 335 | 18.5 |
| No 8. (Siedlce) | 170 | 9.4 |
| No 9. (Żyrardów) | 177 | 9.8 |
| Variable | n | % |
|---|---|---|
| Do you wear glasses or contact lenses? | ||
| Yes | 1081 | 59.7 |
| No | 731 | 40.3 |
| Have you ever been diagnosed with chronic eye diseases? | ||
| Glaucoma | 69 | 3.8 |
| AMD | 13 | 0.7 |
| Diabetic retinopathy | 11 | 0.6 |
| When did you last perform an eye examination? | ||
| In the last month | 35 | 1.9 |
| More than a month ago, but less than 12 months ago | 335 | 18.5 |
| More than a year ago, but less than 2 years ago | 380 | 21.0 |
| More than 2 years ago, but less than 3 years ago | 280 | 15.5 |
| More than 3 years ago | 645 | 35.6 |
| Never | 137 | 7.6 |
| Have you visited an ophthalmologist in the last 2 years? | ||
| Yes | 750 | 41.4 |
| No | 1062 | 58.6 |
| Do you have difficulty accessing an ophthalmologist in your region? | ||
| Yes | 1033 | 57.0 |
| No | 779 | 43.0 |
| What problems with access to an ophthalmologist have you noticed in your place of residence? (n = 1033) | ||
| Waiting time for a visit | 863 | 83.5 |
| Distance of the clinic/ophthalmologist from the place of residence | 79 | 7.6 |
| Transportation to the medical facility | 35 | 3.4 |
| Cost of private visits to the ophthalmologist | 327 | 31.7 |
| Lack of qualified ophthalmologist in the place of residence | 95 | 9.2 |
| In your place of residence (e.g., city, municipality), is there access to an optician’s shop where you can buy glasses or contact lenses? | ||
| Yes | 1511 | 83.4 |
| No | 301 | 16.6 |
| How would you rate your level of knowledge about eye diseases? | ||
| Very low | 281 | 15.5 |
| Rather low | 496 | 27.4 |
| Average | 963 | 53.1 |
| Rather high | 62 | 3.4 |
| Very high | 10 | 0.6 |
| Would you like to improve your knowledge about eye diseases? | ||
| Yes | 1588 | 87.6 |
| No | 224 | 12.4 |
| Self-Declared Prior Medical Diagnosis of Eye Conditions (Before Participation in Screening) | Cases Suspected During the Examination | Newly Suspected Cases | Detected Cases That Are Consistent with the Previous Diagnosis | Cases Declared by the Patient but Not Detected During the Examination Through Screening | ||
|---|---|---|---|---|---|---|
| Glaucoma | n | 69 | 69 | 38 | 31 | 38 |
| % (95%CI) | 3.8 (3.0–4.8) | 3.8 (3.0–4.8) | 2.1 | 1.7 | 2.1 | |
| AMD | n | 13 | 92 | 84 | 8 | 5 |
| % (95%CI) | 0.7 (0.4–1.2) | 5.1 | 4.6 | 0.4 | 0.3 | |
| Diabetic retinopathy | n | 11 | 29 | 21 | 8 | 3 |
| % (95%CI) | 0.6 (0.3–1.1) | 1.6 | 1.2 | 0.4 | 0.2 |
| Newly Detected Suspected Cases of Ophthalmological Disease | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaucoma | AMD | Diabetic Retinopathy | ||||||||||
| Variable | n | % | 95%CI | p | n | % | 95%CI | p | n | % | 95%CI | p |
| Gender | ||||||||||||
| Female (n = 1081) | 22 | 2.0 | 1.4–3.0 | 0.8 | 55 | 5.1 | 3.9–6.6 | 0.3 | 16 | 1.5 | 0.9–2.4 | 0.1 |
| Male (n = 731) | 16 | 2.2 | 1.4–3.5 | 29 | 4.0 | 2.8–5.6 | 5 | 0.7 | 0.3–1.6 | |||
| Age | ||||||||||||
| <30 (n = 73) | 0 | 0.0 | 0.0–5.0 | 0.7 | 0 | 0.0 | 0.0–5.0 | <0.001 | 0 | 0.0 | 0.0–5.0 | <0.001 |
| 30–39 (n = 94) | 1 | 1.1 | 0.2–5.8 | 1 | 1.0 | 0.2–5.8 | 0 | 0.0 | 0.0–3.9 | |||
| 40–49 (n = 292) | 6 | 2.1 | 1.0–4.4 | 2 | 0.7 | 0.2–2.5 | 0 | 0.0 | 0.0–1.3 | |||
| 50–59 (n = 291) | 4 | 1.4 | 0.5–3.5 | 5 | 1.7 | 0.7–4.0 | 1 | 0.3 | 0.1–1.9 | |||
| 60–69 (n = 513) | 12 | 2.3 | 1.3–4.0 | 13 | 2.5 | 1.5–4.3 | 4 | 0.8 | 0.3–2.0 | |||
| 70–79 (n = 465) | 13 | 2.8 | 0.3–2.2 | 43 | 9.2 | 6.9–12.2 | 12 | 2.6 | 1.5–4.5 | |||
| 80+ (n = 84) | 2 | 2.4 | 0.7–8.3 | 20 | 23.8 | 16.0–33.9 | 4 | 4.8 | 1.9–11.6 | |||
| Educational level | ||||||||||||
| Primary (n = 108) | 3 | 2.8 | 1.0–7.9 | 0.2 | 11 | 10.2 | 5.8–17.3 | 0.007 | 4 | 3.7 | 1.5–9.1 | 0.02 |
| Vocational (n = 370) | 12 | 3.2 | 1.9–5.6 | 23 | 6.2 | 4.2–9.2 | 7 | 1.9 | 0.9–3.9 | |||
| Secondary (n = 715) | 15 | 2.1 | 1.3–3.4 | 27 | 3.8 | 2.6–5.4 | 4 | 0.6 | 0.2–1.4 | |||
| Higher (n = 619) | 8 | 1.3 | 0.7–2.5 | 23 | 3.7 | 2.5–5.5 | 6 | 1.0 | 0.4–2.1 | |||
| Taking medications on a regular basis | ||||||||||||
| Yes (n = 1137) | 25 | 2.2 | 1.5–3.2 | 0.7 | 67 | 5.9 | 4.7–7.4 | <0.001 | 21 | 1.8 | 1.2–2.8 | <0.001 |
| No (n = 675) | 13 | 1.9 | 1.1–3.3 | 17 | 2.5 | 1.6–4.0 | 0 | 0.0 | 0.0–0.6 | |||
| Do you smoke cigarettes, use e-cigarettes, or heated tobacco? | ||||||||||||
| Yes (n = 306) | 8 | 2.6 | 1.3–5.1 | 0.5 | 12 | 3.9 | 2.3–6.7 | 0.5 | 4 | 1.3 | 0.5–3.3 | 0.8 |
| No (n = 1506) | 30 | 2.0 | 1.4–2.8 | 72 | 4.8 | 3.8–6.0 | 17 | 1.1 | 0.7–1.8 | |||
| Research site | ||||||||||||
| No 1. (Bodzanów) (n = 159) | 6 | 3.8 | 1.7–8.0 | <0.001 | 8 | 5.0 | 2.6–9.6 | <0.001 | 1 | 0.6 | 0.1–3.5 | 0.7 |
| No 2. (Ciechanów) (n = 289) | 2 | 0.7 | 0.2–2.5 | 11 | 3.8 | 2.1–6.7 | 3 | 1.0 | 0.4–3.0 | |||
| No 3. (Warsaw–Wilanów District) (n = 107) | 3 | 2.8 | 1.0–7.9 | 18 | 16.8 | 10.9–25.0 | 1 | 0.9 | 0.2–5.1 | |||
| No 4. (Legionowo) (n = 108) | 0 | 0.0 | 0.0–3.4 | 0 | 0.0 | 0.0–3.4 | 0 | 0.0 | 0.0–3.4 | |||
| No 5. (Ostrołęka) (n = 148) | 0 | 0.0 | 0.0–2.5 | 5 | 3.4 | 1.5–7.7 | 4 | 2.7 | 1.1–6.7 | |||
| No 6. (Płock) (n = 319) | 4 | 1.3 | 0.5–3.2 | 15 | 4.7 | 2.9–7.6 | 4 | 1.3 | 0.5–3.2 | |||
| No 7. (Radom) (n = 335) | 7 | 2.1 | 1.0–4.3 | 13 | 3.9 | 2.3–6.5 | 3 | 0.9 | 0.3–2.6 | |||
| No 8. (Siedlce) (n = 170) | 0 | 0.0 | 0.0–2.2 | 3 | 1.8 | 0.6–5.1 | 2 | 1.2 | 0.3–4.2 | |||
| No 9. (Żyrardów) (n = 177) | 16 | 9.0 | 5.6–14.2 | 11 | 6.2 | 3.5–10.8 | 3 | 1.7 | 0.6–4.9 | |||
| Factors Associated with the Use of Eye Care Services—Multivariable Logistic Regression | ||||||
|---|---|---|---|---|---|---|
| Have You Visited an Ophthalmologist in the Last 2 Years?—“Yes” | Do you Have Difficulty Accessing an Ophthalmologist in Your Region?—“Yes” | |||||
| Variable | OR | 95%CI | p | OR | 95%CI | p |
| Gender | ||||||
| Female | 1.31 | 1.07–1.59 | 0.008 | 1.65 | 1.36–2.01 | <0.001 |
| Male | Reference | Reference | ||||
| Age | ||||||
| <30 | Reference | Reference | ||||
| 30–39 | 0.37 | 0.20–0.71 | 0.003 | 2.33 | 1.17–4.65 | 0.02 |
| 40–49 | 0.43 | 0.25–0.74 | 0.002 | 3.15 | 1.73–5.71 | <0.001 |
| 50–59 | 0.43 | 0.25–0.73 | 0.002 | 3.73 | 2.05–6.77 | <0.001 |
| 60–69 | 0.60 | 0.36–0.99 | 0.04 | 5.51 | 3.08–9.86 | <0.001 |
| 70–79 | 0.80 | 0.48–1.33 | 0.4 | 4.71 | 2.62–8.47 | <0.001 |
| 80+ | 1.07 | 0.56–2.05 | 0.8 | 5.86 | 2.84–12.07 | <0.001 |
| Educational level | ||||||
| Primary | Reference | Reference | ||||
| Vocational | 1.06 | 0.67–1.66 | 0.8 | 0.99 | 0.62–1.56 | 0.9 |
| Secondary | 1.14 | 0.74–1.75 | 0.6 | 0.92 | 0.60–1.43 | 0.7 |
| Higher | 1.93 | 1.25–3.00 | 0.003 | 0.85 | 0.55–1.33 | 0.5 |
| Taking medications on a regular basis | ||||||
| Yes | 1.29 | 1.04–1.61 | 0.02 | 1.23 | 0.99–1.53 | 0.06 |
| No | Reference | Reference | ||||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kamińska, A.; Adamska, O.; Kamiński, M.; Pierzak, A.; Lockley, A.; Rybicki, S.; Jankowski, M.; Sierpiński, R. Opportunistic Eye Disease Screening in Mazovia, Poland: Lessons from a Local Government Program: “Good Vision for Mazovians”. Healthcare 2025, 13, 2456. https://doi.org/10.3390/healthcare13192456
Kamińska A, Adamska O, Kamiński M, Pierzak A, Lockley A, Rybicki S, Jankowski M, Sierpiński R. Opportunistic Eye Disease Screening in Mazovia, Poland: Lessons from a Local Government Program: “Good Vision for Mazovians”. Healthcare. 2025; 13(19):2456. https://doi.org/10.3390/healthcare13192456
Chicago/Turabian StyleKamińska, Agnieszka, Olga Adamska, Maciej Kamiński, Anna Pierzak, Andrew Lockley, Szymon Rybicki, Mateusz Jankowski, and Radosław Sierpiński. 2025. "Opportunistic Eye Disease Screening in Mazovia, Poland: Lessons from a Local Government Program: “Good Vision for Mazovians”" Healthcare 13, no. 19: 2456. https://doi.org/10.3390/healthcare13192456
APA StyleKamińska, A., Adamska, O., Kamiński, M., Pierzak, A., Lockley, A., Rybicki, S., Jankowski, M., & Sierpiński, R. (2025). Opportunistic Eye Disease Screening in Mazovia, Poland: Lessons from a Local Government Program: “Good Vision for Mazovians”. Healthcare, 13(19), 2456. https://doi.org/10.3390/healthcare13192456

